- Home
- ELDN vs ELLO Comparison
ELDN vs ELLO Comparison
Compare ELDN & ELLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELDN
- ELLO
- Stock Information
- Founded
- ELDN 2004
- ELLO 1987
- Country
- ELDN United States
- ELLO Israel
- Employees
- ELDN N/A
- ELLO N/A
- Industry
- ELDN Biotechnology: Pharmaceutical Preparations
- ELLO Electric Utilities: Central
- Sector
- ELDN Health Care
- ELLO Utilities
- Exchange
- ELDN Nasdaq
- ELLO Nasdaq
- Market Cap
- ELDN 202.4M
- ELLO 222.3M
- IPO Year
- ELDN N/A
- ELLO 1995
- Fundamental
- Price
- ELDN $2.37
- ELLO $18.13
- Analyst Decision
- ELDN Strong Buy
- ELLO
- Analyst Count
- ELDN 2
- ELLO 0
- Target Price
- ELDN $12.50
- ELLO N/A
- AVG Volume (30 Days)
- ELDN 640.2K
- ELLO 2.0K
- Earning Date
- ELDN 11-11-2025
- ELLO 09-25-2025
- Dividend Yield
- ELDN N/A
- ELLO N/A
- EPS Growth
- ELDN N/A
- ELLO N/A
- EPS
- ELDN 0.21
- ELLO 0.43
- Revenue
- ELDN N/A
- ELLO $44,405,534.00
- Revenue This Year
- ELDN N/A
- ELLO N/A
- Revenue Next Year
- ELDN N/A
- ELLO N/A
- P/E Ratio
- ELDN $11.10
- ELLO $47.69
- Revenue Growth
- ELDN N/A
- ELLO N/A
- 52 Week Low
- ELDN $2.32
- ELLO $11.30
- 52 Week High
- ELDN $5.54
- ELLO $20.81
- Technical
- Relative Strength Index (RSI)
- ELDN 35.17
- ELLO 51.94
- Support Level
- ELDN $2.41
- ELLO N/A
- Resistance Level
- ELDN $2.84
- ELLO $18.22
- Average True Range (ATR)
- ELDN 0.13
- ELLO 0.35
- MACD
- ELDN 0.00
- ELLO -0.67
- Stochastic Oscillator
- ELDN 10.48
- ELLO 94.08
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
About ELLO Ellomay Capital Ltd (Israel)
Ellomay Capital Ltd is a renewable energy company. It develops and operates renewable energy projects in Europe, the USA, and Israel, employing diverse technologies such as solar power, natural gas, pumped hydro, and waste-to-energy solutions.